Search

Your search keyword '"A. Hannequin"' showing total 1,872 results

Search Constraints

Start Over You searched for: Author "A. Hannequin" Remove constraint Author: "A. Hannequin"
1,872 results on '"A. Hannequin"'

Search Results

1. Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU): Trial Satisfaction and Attitudes towards Future Clinical Trials

2. Phenotype and imaging features associated with APP duplications

3. Parenting styles in caregivers of children with Autism Spectrum Disorder and effects of service dogs

4. Comparative Analysis of Lumbar Disc Herniation Treatment Outcomes: Conventional vs. Endoscopic Techniques in a Prospective Multicenter Study

5. Gene Expression Imputation Across Multiple Tissue Types Provides Insight Into the Genetic Architecture of Frontotemporal Dementia and Its Clinical Subtypes

6. Phenotype and imaging features associated with APP duplications

7. Comparison of Pittsburgh compound B and florbetapir in cross‐sectional and longitudinal studies

8. Prioritization of Drug Targets for Neurodegenerative Diseases by Integrating Genetic and Proteomic Data From Brain and Blood

9. Primary brain calcification: an international study reporting novel variants and associated phenotypes.

10. Protein network analysis reveals selectively vulnerable regions and biological processes in FTD

11. Analysis of shared heritability in common disorders of the brain

12. Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study

13. Analysis of shared heritability in common disorders of the brain.

14. Genetically elevated high‐density lipoprotein cholesterol through the cholesteryl ester transfer protein gene does not associate with risk of Alzheimer's disease

15. Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease.

16. Clinical and neuropathological diversity of tauopathy in MAPT duplication carriers

17. A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer’s disease

19. A novel Alzheimer disease locus located near the gene encoding tau protein.

20. Comparison of Pittsburgh compound B and florbetapir in cross‐sectional and longitudinal studies

21. Mutations in XPR1 cause primary familial brain calcification associated with altered phosphate export.

22. Somatic variants in autosomal dominant genes are a rare cause of sporadic Alzheimer's disease

23. Frontotemporal dementia and its subtypes: a genome-wide association study

24. Parenting styles in caregivers of children with Autism Spectrum Disorder and effects of service dogs.

25. Plasma amyloid levels within the Alzheimer's process and correlations with central biomarkers

26. Added value of 18F-florbetaben amyloid PET in the diagnostic workup of most complex patients with dementia in France: A naturalistic study

27. Genetically elevated high‐density lipoprotein cholesterol through the cholesteryl ester transfer protein gene does not associate with risk of Alzheimer's disease

28. New insights into the genetic etiology of Alzheimer's disease and related dementias

31. Prioritization of Drug Targets for Neurodegenerative Diseases by Integrating Genetic and Proteomic Data From Brain and Blood

32. How many patients are eligible for disease-modifying treatment in Alzheimer’s disease? A French national observational study over 5 years

35. Plasma progranulin levels for frontotemporal dementia in clinical practice: a 10-year French experience

39. 17q21.31 duplication causes prominent tau-related dementia with increased MAPT expression

40. Primary progressive aphasias associated with C9orf72 expansions: Another side of the story

42. Étude rétrospective multicentrique de 15 cas adultes de xanthomatose cérébrotendineuse : aspects cliniques et paracliniques typiques et atypiques

43. Relations between C9orf72 expansion size in blood, age at onset, age at collection and transmission across generations in patients and presymptomatic carriers

44. Early Cognitive, Structural, and Microstructural Changes in Presymptomatic C9orf72 Carriers Younger Than 40 Years

45. Author Correction: Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing

47. A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer’s disease

50. APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: A genetic screening study of familial and sporadic cases.

Catalog

Books, media, physical & digital resources